Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.41 - $0.86 $1,309 - $2,747
3,195 Added 19.87%
19,273 $8,000
Q1 2024

May 20, 2024

BUY
$0.58 - $0.92 $9,325 - $14,791
16,078 New
16,078 $11,000
Q2 2022

Aug 09, 2022

BUY
$2.39 - $4.15 $32,788 - $56,933
13,719 New
13,719 $33,000
Q2 2021

Sep 17, 2021

SELL
$3.75 - $6.72 $81,217 - $145,541
-21,658 Closed
0 $0
Q1 2021

May 19, 2021

SELL
$3.93 - $6.99 $5,226 - $9,296
-1,330 Reduced 5.79%
21,658 $89,000
Q4 2020

Feb 24, 2021

BUY
$3.81 - $4.73 $87,584 - $108,733
22,988 New
22,988 $88,000

Others Institutions Holding PPBT

# of Institutions
1
Shares Held
15
Call Options Held
0
Put Options Held
0

About PURPLE BIOTECH LTD.


  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $40.1M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.